Skip to main content

Table 3 Trial primary safety outcome

From: Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study

Primary safety outcome

Clopidogrel with Aspirin (n = 93)

Clopidogrel with Indobufen (n = 89)

χ2

Hazard Ratio

(95% CI)

P

Bleeding(%)

8(8.6)

1(1.1)

-

0.92 (0.87–0.99)

0.035

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us